These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9505994)

  • 21. Absence of interaction between tiagabine, a new antiepileptic drug, and the benzodiazepine triazolam.
    Richens A; Marshall RW; Dirach J; Jansen JA; Snel S; Pedersen PC
    Drug Metabol Drug Interact; 1998; 14(3):159-77. PubMed ID: 10366992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tiagabine: new preparation. Refractory partial epilepsy: another alternative.
    Prescrire Int; 1998 Aug; 7(36):99-101. PubMed ID: 10342943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The clinical pharmacokinetics of the new antiepileptic drugs.
    Perucca E
    Epilepsia; 1999; 40 Suppl 9():S7-13. PubMed ID: 10612356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tiagabine (gabitril) experience in children.
    Pellock JM
    Epilepsia; 2001; 42 Suppl 3():49-51. PubMed ID: 11520324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuropsychological effects of tiagabine, a potential new antiepileptic drug.
    Sveinbjornsdottir S; Sander JW; Patsalos PN; Upton D; Thompson PJ; Duncan JS
    Seizure; 1994 Mar; 3(1):29-35. PubMed ID: 8044451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The clinical pharmacokinetics of the newer antiepileptic drugs. Focus on topiramate, zonisamide and tiagabine.
    Perucca E; Bialer M
    Clin Pharmacokinet; 1996 Jul; 31(1):29-46. PubMed ID: 8827398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of pharmacokinetic drug interactions between tiagabine and carbamazepine or phenytoin.
    Gustavson LE; Cato A; Boellner SW; Cao GX; Qian JX; Guenther HJ; Sommerville KW
    Am J Ther; 1998 Jan; 5(1):9-16. PubMed ID: 10099032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tolerability of tiagabine: a prospective open-label study.
    Bauer J; Bergmann A; Reuber M; Stodieck SR; Genton P
    Epileptic Disord; 2002 Dec; 4(4):257-60. PubMed ID: 12600812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tiagabine.
    Schachter SC
    Epilepsia; 1999; 40 Suppl 5():S17-22. PubMed ID: 10530690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deliberate overdose with the novel anticonvulsant tiagabine.
    Leach JP; Stolarek I; Brodie MJ
    Seizure; 1995 Jun; 4(2):155-7. PubMed ID: 7670769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of new antiepileptic drugs.
    Gram L
    Epilepsia; 1996; 37 Suppl 6():S12-6. PubMed ID: 8941037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increase in tiagabine serum concentration with coadministration of gemfibrozil.
    Burstein AH; Boudreau EA; Theodore WH
    Ann Pharmacother; 2009 Feb; 43(2):379-82. PubMed ID: 19193595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tiagabine adjunctive therapy in children with refractory epilepsy: a single-blind dose escalating study.
    Uldall P; Bulteau C; Pedersen SA; Dulac O; Lyby K
    Epilepsy Res; 2000 Dec; 42(2-3):159-68. PubMed ID: 11074188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tiagabine.
    Pierce MW; Suzdak PD; Gustavson LE; Mengel HB; McKelvy JF; Mant T
    Epilepsy Res Suppl; 1991; 3():157-60. PubMed ID: 1777074
    [No Abstract]   [Full Text] [Related]  

  • 35. The pharmacokinetic inter-relationship of tiagabine in blood, cerebrospinal fluid and brain extracellular fluid (frontal cortex and hippocampus).
    Wang X; Ratnaraj N; Patsalos PN
    Seizure; 2004 Dec; 13(8):574-81. PubMed ID: 15519917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tiagabine for complex partial seizures: a randomized, add-on, dose-response trial.
    Uthman BM; Rowan AJ; Ahmann PA; Leppik IE; Schachter SC; Sommerville KW; Shu V
    Arch Neurol; 1998 Jan; 55(1):56-62. PubMed ID: 9443711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tiagabine therapy for complex partial seizures. A dose-frequency study. The Tiagabine Study Group.
    Sachdeo RC; Leroy RF; Krauss GL; Drake ME; Green PM; Leppik IE; Shu VS; Ringham GL; Sommerville KW
    Arch Neurol; 1997 May; 54(5):595-601. PubMed ID: 9152116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retention rates of new antiepileptic drugs in localization-related epilepsy: a single-center study.
    Peltola J; Peltola M; Auvinen A; Raitanen J; Fallah M; Keränen T
    Acta Neurol Scand; 2009 Jan; 119(1):55-60. PubMed ID: 18616622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug-induced nonconvulsive status epilepticus with low dose of tiagabine.
    Fitzek S; Hegemann S; Sauner D; Bönsch D; Fitzek C
    Epileptic Disord; 2001 Sep; 3(3):147-50. PubMed ID: 11679307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Choice and use of newer anticonvulsant drugs in older patients.
    Willmore LJ
    Drugs Aging; 2000 Dec; 17(6):441-52. PubMed ID: 11200305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.